Skip to main content
Log in

Verkürzte biologische Halbwertszeit von 1,2-3H-Aldosteron bei drei nephrektomierten Patienten

  • Kurze Wissenschaftliche Mitteilungen
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Zusammenfassung

Die biologische Halbwertszeit von Aldosteron, die normalerweise 30–40 min beträgt, war bei drei nephrektomierten Patienten auf 15, 19 und 20 min verkürzt.

Summary

The biological half-time of labeled aldosterone of 30 to 40 minutes in normal man was 15, 19 and 20 minutes in three nephrectomized patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Peterson, R. E.: Aldosterone metabolism. Recent Progr. Hormone Res.15, 231 (1959).

    Google Scholar 

  2. Coppage, W. S., D. Island, A. E. Cooner, andG. W. Liddle: Metabolism of aldosterone in normal subjects and patients with cirrhosis. Clin. Res.9, 177 (1961).

    Google Scholar 

  3. Tait, J. F., S. A. S. Tait, B. Little, andK. R. Laumas: The disappearance of 1,2-3H-aldosterone in the plasma of normal subjects. J. clin. Invest.40, 72 (1961).

    Google Scholar 

  4. Luetscher, J. A., A. J. Dowdy, A. M. Callaghan, andA. P. Cohn: Studies of secretion and metabolism of aldosterone and cortisol. Trans. Ass. Amer. Phycns75, 293 (1962).

    Google Scholar 

  5. Coppage, W. S., D. P. Island, A. E. Cooner, andG. W. Liddle: The metabolism of aldosterone in normal subjects and in patients with cirrhosis. J. clin. Invest.41, 1672 (1962).

    Google Scholar 

  6. Wolff, H. P., D. Lommer u.M. Torbica: Untersuchungen über das Plasmaaldosteron und den Aldosteronstoffwechsel bei Gesunden, Herz-, Leber- und Nierenkranken. Schweiz. med. Wschr.95, 387 (1965).

    Google Scholar 

  7. Tait, J. F., B. Little, S. A. Tait, andC. Flood: The metabolic clearance rate of aldosterone in pregnant and nonpregnant subjects estimated by both single injection and constant infusion methods. J. clin. Invest.41, 2093 (1962).

    Google Scholar 

  8. Bougas, J., C. Flood, B. Little, J. F. Tait, S. A. S. Tait, andR. Underwood: Dynamic aspects of aldosterone metabolism, p. 25. Oxford: Blackwell Sci. Publ. 1964.

    Google Scholar 

  9. Camargo C. A., A. J. Dowdy, E. W. Hancock, andJ. A. Luetscher: Decreased plasma clearance and hepatic extraction of aldosterone in patients with heart failure. J. clin. Invest.44 356 (1965).

    Google Scholar 

  10. Davis, J. O., M. J. Olichney, T. C. Brown, andP. F. Binnion: Metabolism of aldosterone in several experimental situations with altered aldosterone secretion. J. clin. Invest.44, 1433 (1965).

    Google Scholar 

  11. Bledsoe, T., G. W. Liddle, A. Riondel, D. P. Island, D. Bloomfield, andB. Sinclair-Smith: Comparative fates of intravenously and orally administered aldosterone: Evidence for extrahepatic formation of acid-hydrolysable conjugate in man. J. clin. Invest.45, 264 (1966).

    Google Scholar 

  12. Flood, C., G. Pincus, J. F. Tait, S. A. S. Tait, andS. Willoughby: The metabolism and secretion of aldosterone in elderly subjects. J. clin. Invest.46, 690 (1967).

    Google Scholar 

  13. Luetscher, J. A., E. W. Hancock, C. A. Carmago, A. J. Dowdy, andG. W. Nokes: Conjugation of 1,2-3H-aldosterone in human liver and kidneys and renal extraction of aldosterone and labeled conjugates from blood plasma. J. clin. Endocr.25, 628 (1965).

    Google Scholar 

  14. Deck, K., andW. Siegenthaler: Further experimental evidence for the formation of the acid hydrolysable conjugate of aldosterone by the kidney. Acta endocr. (Kbh.)51, 637 (1967).

    Google Scholar 

  15. Deck, K., andW. Siegenthaler: Transport of aldosterone and of the acid labile conjugate of aldosterone by tubular cells of the kidney. Acta endocr. (Kbh.)51, 648 (1967).

    Google Scholar 

  16. Möhring, J., B. Möhring, P. Endres u.W. Siegenthaler: Zur Bildung von 18-Aldosteronglucuronid in den Nieren des Hundes. Z. ges. exp. Med. (im Druck) (1967).

  17. Möhring, J., B. Möhring u.W. Siegenthaler: Zur Bildung von 18-Aldosteronglucuronid in den Nieren des Menschen. Z. ges. exp. Med. (im Druck) (1967).

  18. Chart, J. J., E. S. Gordon, P. Helmer, andM. Lesher: Metabolism of salt-retaining hormone by surviving liver slices. J. clin. Invest.39, 320 (1956).

    Google Scholar 

  19. Yates, F. E., J. Urquhart, andA. L. Herbst: Impairment of the enzymatic inactivation of adrenal cortical hormone following passive venous congestion of the liver. Endocr. Soc. Abstr.42, 17 (1960).

    Google Scholar 

  20. Ayres, C. R., J. O. Davis, F. Liebermann, C. C. J. Carpenter, andM. Bergmann: The effect of chronic hepatic venous congestion on the metabolism of d,1-aldosterone and d-aldosterone. J. clin. Invest.41, 884 (1962).

    Google Scholar 

  21. Tomkins, G.: Enzymatic mechanism of hormone metabolism. I. Oxidation-reduction of the steroid nucleus. Recent Progr. Hormone Res.12, 125 (1956).

    Google Scholar 

  22. Luetscher, J. A., A. P. Cohn, C. A. Camargo, A. J. Dowdy, andA. M. Callaghan: Aldosterone secretion and metabolism in hyperthyroidism and myxödema. J. clin. Endocr.23, 873 (1963).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Möhring, J., Siegenthaler, W. & Weidmann, P. Verkürzte biologische Halbwertszeit von 1,2-3H-Aldosteron bei drei nephrektomierten Patienten. Klin Wochenschr 46, 47–49 (1968). https://doi.org/10.1007/BF01725303

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01725303

Navigation